抵消器-探索受体诱饵陷阱的可能性，以此作为抗逆转录病毒的方法

Title:Cancellers - Exploring the Possibility of Receptor Decoy Traps As a Superior Anti-Retroviral Strategy

Volume: 17 Issue: 6

Author(s): Sundararaj Stanley Jeremiah, Kenji Ohba and Naoki Yamamoto

Affiliation:

关键词: 抵消器，载体红细胞，功能性治愈，遗传操作，造血干细胞，HIV，受体诱饵陷阱。

摘要: The global Human Immunodeficiency Virus (HIV) pandemic is still spreading due to the lack of ideal anti-retroviral measures and their availability. Till date, all attempts to produce an efficient vaccine have ended with unsatisfactory results. The highly active anti-retroviral therapy (HAART) is the only effective weapon currently available and is widely being used for curtailing the HIV pandemic. However, the HAART is also expected to fail in the near future due to the emergence and dissemination of antiviral resistance. This review sheds light on the reasons for the failure of the conventional anti-viral measures against HIV and the novel anti-retroviral strategies currently being developed. The various principles to be considered for the success of a novel anti-retroviral strategy are elaborately emphasized and an innovative concept is proposed on these lines. The proposed concept intends to use receptor decoy traps (RDT) called cancellers which are erythrocytes expressing the HIV entry receptors on their surface. If successfully developed, the cancellers would be capable of active targeting of the free HIV particles leading to the trapping of the viruses within the canceller, resulting in the neutralization of infectivity of the trapped virus. The possible ways of translating this concept into reality and the probable hurdles that can be encountered in the process are subsequently discussed. Also, the scope of cancellers in therapeutic and/or preventive strategies against HIV infection is envisaged upon their successful development.

Cite this article as:

Sundararaj Stanley Jeremiah, Kenji Ohba and Naoki Yamamoto , Cancellers - Exploring the Possibility of Receptor Decoy Traps As a Superior Anti-Retroviral Strategy, Current Drug Targets 2016; 17 (6) . https://dx.doi.org/10.2174/138945011706160324125824